Detalles de la búsqueda
1.
2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunction-associated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.
Diabetol Metab Syndr;
16(1): 23, 2024 Jan 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38238868
2.
Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso).
Arch Endocrinol Metab;
67(6): e230123, 2023 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38048417
3.
Portuguese-Brazilian evidence-based guideline on the management of hyperglycemia in type 2 diabetes mellitus.
Diabetol Metab Syndr;
12: 45, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32489427
4.
Correction: 2024 UPDATE: the Brazilian Diabetes Society position on the management of metabolic dysfunctionassociated steatotic liver disease (MASLD) in people with prediabetes or type 2 diabetes.
Diabetol Metab Syndr;
16(1): 54, 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38419114
5.
Brazilian evidence-based guideline for screening, diagnosis, treatment, and follow-up of metabolic dysfunction-associated steatotic liver disease (MASLD) in adult individuals with overweight or obesity: A joint position statement from the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Hepatology (SBH), and Brazilian Association for the Study of Obesity and Metabolic Syndrome (Abeso)
Arch. endocrinol. metab. (Online);
67(6): e230123, Mar.-Apr. 2023. tab, graf
Artículo
en Inglés
| LILACS-Express
| ID: biblio-1527754
6.
Brazilian Position Statement for Familial Chylomicronemia Syndrome - 2023. / Posicionamento Brasileiro sobre Síndrome da Quilomicronemia Familiar 2023.
Arq Bras Cardiol;
120(4): e20230203, 2023 03.
Artículo
en Inglés, Portugués
| MEDLINE | ID: mdl-37075362
7.
Dipeptidyl peptidase-4 levels are increased and partially related to body fat distribution in patients with familial partial lipodystrophy type 2.
Diabetol Metab Syndr;
9: 26, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28450900
8.
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM).
Diabetol Metab Syndr;
9: 53, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28725272
9.
[The endocannabinoid system: a new paradigm in the metabolic syndrome treatment]. / O sistema endocanabinóide: novo paradigma no tratamento da síndrome metabólica.
Arq Bras Endocrinol Metabol;
50(2): 390-9, 2006 Apr.
Artículo
en Portugués
| MEDLINE | ID: mdl-16767305
10.
Posicionamento Brasileiro sobre Síndrome da Quilomicronemia Familiar - 2023 / Brazilian Position Statement for Familial Chylomicronemia Syndrome - 2023
Arq. bras. cardiol;
120(4): e20230203, 2023. tab, graf
Artículo
en Portugués
| LILACS-Express
| ID: biblio-1429800
11.
Diretriz brasileira baseada em evidências sobre prevenção de doenças cardiovasculares em pacientes com diabetes: posicionamento da Sociedade Brasileira de Diabetes (SBD), da Sociedade Brasileira de Cardiologia (SBC) e da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM).
Arq Bras Cardiol;
109(6 Suppl 1): 1-31, 2017 12.
Artículo
en Portugués
| MEDLINE | ID: mdl-29489927
12.
Diretriz brasileira baseada em evidências sobre prevenção de doenças cardiovasculares em pacientes com diabetes: posicionamento da Sociedade Brasileira de Diabetes (SBD), da Sociedade Brasileira de Cardiologia (SBC) e da Sociedade Brasileira de Endocrinologia e Metabologia (SBEM) / Brazilian evidence-based guideline on cardiovascular disease prevention in patients with diabetes: positioning of the Brazilian Society of Diabetes (SBD), the Brazilian Society of Cardiology (SBC) and the Brazilian Society of Endocrinology and Metabology (SBEM)
Arq. bras. cardiol;
109(6,supl.1): 1-31, dez. 2017. tab
Artículo
en Portugués
| LILACS | ID: biblio-887990
13.
O sistema endocanabinóide: novo paradigma no tratamento da síndrome metabólica / The endocannabinoid system: a new paradigm in the metabolic syndrome treatment
Arq. bras. endocrinol. metab;
50(2): 390-399, abr. 2006. ilus, tab
Artículo
en Portugués
| LILACS | ID: lil-435166
14.
Hiperplasia embrionária epitelial da cápsula de Bowman pósðdiálise crônica simulando nefroblastomatose: relato de caso / Embryonal hiperplasia of Bowman's capsule epithelium after dialysis simulating nephroblastomatosis: case report
J. bras. patol. med. lab;
38(1): 51-54, mar. 2002. ilus
Artículo
en Portugués
| LILACS | ID: lil-316941
Resultados
1 -
14
de 14
1
Próxima >
>>